Drug class
Fluoroquinolone antibacterial; DNA gyrase and topoisomerase IV inhibitor
Mechanism of action
Inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication, transcription and repair and producing bactericidal activity against susceptible organisms.
General use cases
- Historically used for selected uncomplicated urinary-tract infections and bacterial prostatitis in countries where norfloxacin remains authorised; many jurisdictions restrict fluoroquinolone use due to potentially serious and long-lasting adverse effects
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
